🔎 Trials Near Me

Home › NCT07618104

Pornography Abstinence and Nocturnal Erections in Adult Men

RecruitingObservational studyHealthy volunteers welcome

A Real-World Observational Study Evaluating the Effects of 30 Days of Pornography Abstinence on Nocturnal Penile Tumescence, Sexual Function, and Well-Being in Adult Men

Who can join

Ages 18 and older · Men · Healthy volunteers welcome

Full eligibility criteria
Inclusion Criteria:

* Adult males of legal age of consent
* Willingness to attempt pornography abstinence
* Ability to use a wearable device during sleep
* Ability to complete electronic surveys
* Willingness to purchase the study device

Exclusion Criteria:

* Have a history of significant sexual dysfunction requiring active medical treatment
* Have current or uncontrolled mental health disorders
* Have a history of addictive behaviors that may be exacerbated by abstinence
* Are undergoing hormonal therapy or treatment affecting sexual function
* Are experiencing unstable interpersonal or relationship stressors
* Have significant concerns about privacy related to sexual health data
* Have cultural or religious considerations that could cause distress

About the study

The effects of pornography use on male sexual health remain uncertain, with mixed findings across existing literature and substantial variability at the individual level. This observational study is designed to help participants evaluate how a 30-day period of pornography abstinence affects their own sexual health and well-being, with a specific focus on nocturnal penile tumescence as a physiological biomarker.

Participants will complete a short baseline observation period during which they maintain their usual pornography consumption patterns, followed by a 30-day abstinence period. Objective nocturnal erection data will be collected using a connected wearable device, alongside validated self-report questionnaires assessing erectile function, sexual desire, mood, energy, and emotional well-being. Participants serve as their own control, allowing for within-person comparisons of outcomes before and during the abstinence period.

What is being tested

Sponsor: Efforia, Inc · Participants: 100 · Started: Sep 22, 2025

Contact the study team

Official record on ClinicalTrials.gov — NCT07618104

Locations in the U.S.

New YorkEfforia, New York

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.